Home › Funds › Blue Owl Capital Holdings LP › SGMT

Blue Owl Capital Holdings LP position in SGMT

SAGIMET BIOSCIENCES INC · Health Care

Blue Owl Capital Holdings LP reported holding 365,400 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$201K, representing 0.04% of its reported portfolio and ranking #40 among its reported holdings. Blue Owl Capital Holdings LP has disclosed SGMT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)365.40K sh
Reported value held$200.97K
Portfolio Weight0.04%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's SGMT position evolved

Blue Owl Capital Holdings LP first disclosed a stake in SGMT in Q4 2023 at 355,377 shares (US$1.9M). The position peaked in Q2 2025 at 1,328,351 shares, worth US$10.1M. Across 12 filings, Blue Owl Capital Holdings LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 365,400 shares valued at US$201K — a reduction of -895,144 shares quarter over quarter.. Notable position changes include a 371% increase in Q1 2024 (shares fell 37% over the following quarter), a 73% trim in Q1 2026 (shares rose 48% over the following quarter), a 278% increase in Q2 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 355.38K $1.93M New
Q1 2024 1.67M $9.07M Add
Q2 2024 1.67M $5.72M Hold
Q3 2024 1.67M $4.64M Hold
Q4 2024 1.32M $5.96M Reduce
Q1 2025 1.33M $4.33M Hold
Q2 2025 1.33M $10.12M Hold
Q3 2025 1.33M $9.11M Hold
Q4 2025 1.24M $7.36M Reduce
Q1 2026 333.88K $1.74M Reduce
Q2 2026 1.26M $9.74M Add
Q3 2026 365.40K $200.97K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SGMT and 13F data

SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$37.0M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGMT

All SGMT fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held SGMT?

Blue Owl Capital Holdings LP has disclosed SGMT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Blue Owl Capital Holdings LP's current position in SGMT?

As of Q3 2026, Blue Owl Capital Holdings LP holds 365.40K shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $200.97K, representing 0.04% of its reported portfolio and ranking #40.

Has Blue Owl Capital Holdings LP been buying or selling SGMT?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP reduced its position in SGMT. The position peaked in Q2 2025 at 1.33M shares.

Which other funds hold SGMT?

Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.